Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Payables: 2009-2025

Historic Payables for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $6.2 million.

  • Innoviva's Payables rose 49.71% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year increase of 33.59%. This contributed to the annual value of $2.1 million for FY2024, which is 68.26% down from last year.
  • According to the latest figures from Q3 2025, Innoviva's Payables is $6.2 million, which was up 16.00% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's Payables ranged from a high of $6.7 million in Q4 2023 and a low of $14,000 during Q1 2021.
  • Moreover, its 3-year median value for Payables was $4.6 million (2023), whereas its average is $4.2 million.
  • Per our database at Business Quant, Innoviva's Payables crashed by 88.52% in 2021 and then spiked by 14,310.00% in 2022.
  • Over the past 5 years, Innoviva's Payables (Quarterly) stood at $27,000 in 2021, then skyrocketed by 10,785.19% to $2.9 million in 2022, then spiked by 128.55% to $6.7 million in 2023, then tumbled by 68.26% to $2.1 million in 2024, then skyrocketed by 49.71% to $6.2 million in 2025.
  • Its Payables stands at $6.2 million for Q3 2025, versus $5.4 million for Q2 2025 and $4.7 million for Q1 2025.